Is Pharmaids Pharmaceuticals Ltd halal to invest in?

According to Musaffa's Shariah screening methodology, Pharmaids Pharmaceuticals Ltd (524572.BO) is currently classified as HALAL as of January 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Pharmaids Pharmaceuticals Ltd a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Pharmaids Pharmaceuticals Ltd using these criteria to determine its compliance status.

Can Muslims buy shares of Pharmaids Pharmaceuticals Ltd?

Muslim investors may consider investing in Pharmaids Pharmaceuticals Ltd if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Pharmaids Pharmaceuticals Ltd classified as HALAL?

Musaffa determines the Shariah status of Pharmaids Pharmaceuticals Ltd by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Pharmaids Pharmaceuticals Ltd updated?

The Shariah compliance status of Pharmaids Pharmaceuticals Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Pharmaids Pharmaceuticals Ltd become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Pharmaids Pharmaceuticals Ltd?

You can check the latest Shariah compliance status of Pharmaids Pharmaceuticals Ltd on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Pharmaids Pharmaceuticals Ltd 524572.BO

₹29.61 ₹0.39 (1.30%) 1D

Last Updated: May 15, 12:00 AM·BSE

524572.BO Shariah Compliance

Screening Methodology: AAOIFI

HALAL

Last Updated: January 12, 2026

Report Source: 2026 2nd Quarter Report

Pharmaids Pharmaceuticals Ltd. Stock Analysis 524572.BO

India Health Care Nano Cap Report: Q2, 2026

Pharmaids Pharmaceuticals Ltd. engages in contract research and manufacturing services. The company employs 28 full-time employees The firm is engaged in the business of trading and manufacturing of generics, bulk drugs, and intermediaries, and other. The firm operates through Bulk Drugs and Intermediates segment. Its specialty chemicals products include Retinol, DL Alpha Tocopherol, D Pantothenate, Cyanocobalamin, Pyridoxine Hcl, Thiamine, Nicotinic Acid, Water Sol. Vitamin E, Coenzyme Q10 and D-Biotin. Its skin care products include Best care hands, Hands Sanitizer, Moisturizing Cream, Skinsure Plus, SkinSure Ultra, Alcohol Gel and Barrier Cream. Its hospital care products include Xepi Rub M, Facein Spray, Sod Hypochlorite, Sanmedin, Strumen G, Strumen TRIACID, Facein Eco, Facein Power 256, Facein Spray, Sod Hypochlorite, Wipes and PPE. Its generic products include Linzomust, Benfoshine, Duojoint, and other.

Key Statistics of Pharmaids Pharmaceuticals Ltd (524572.BO)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

₹29.39₹31.40

Today's Open

₹30.00

Volume

2905.00

P/E Ratio (TTM)

52 Week Range

₹27.10₹73.45

Market Cap

1.09B

Avg. Volume

9027.73

Dividend Yield

Financial Metrics & Statements of Pharmaids Pharmaceuticals Ltd (524572.BO)

FAQ's for Pharmaids Pharmaceuticals Ltd (524572.BO)

According to Musaffa’s Shariah screening methodology, Pharmaids Pharmaceuticals Ltd (524572.BO) is currently classified as HALAL as of January 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.